(Q46926442)

26 December 2017

title

Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma (English)

1 reference

26 December 2017

0 references

1 reference

1 reference

Julie Gehl

3

0 references

author name string

Henrik Schmidt

1

1 reference

26 December 2017

Julia Sidenius Johansen

2

1 reference

26 December 2017

Poul F Geertsen

4

1 reference

26 December 2017

Kirsten Fode

5

1 reference

26 December 2017

Hans von der Maase

6

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

26 December 2017

published in

Cancer

1 reference

26 December 2017

volume

106

1 reference

26 December 2017

issue

5

1 reference

26 December 2017

page(s)

1130-1139

1 reference

26 December 2017

Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

Human synovial cells secrete a 39 kDa protein similar to a bovine mammary protein expressed during the non-lactating period

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Improving survival in patients with high-risk and metastatic melanoma: immunotherapy leads the way.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Identification of proteins secreted by human osteoblastic cells in culture

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Serum YKL-40 is increased in patients with hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Plasma YKL‐40, as a prognostic tumor marker in recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Serum YKL-40 and colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Serum YKL-40: A new potential marker of prognosis and location of métastases of patients with recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

High serum YKL-40 level in patients with small cell lung cancer is related to early death

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Early detection and prognosis of ovarian cancer using serum YKL-40.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

A phase II study of outpatient subcutaneous histamine dihydrochloride, interleukin-2 and interferon-alpha in patients with metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Constructing time-specific reference ranges.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Extracellular matrix signaling: integration of form and function in normal and malignant cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

The role of fibroblasts in tumor behavior

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Inflammation and cancer: back to Virchow?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Role of infiltrated leucocytes in tumour growth and spread

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Tumour-educated macrophages promote tumour progression and metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21678

7 January 2021

Identifiers

DOI

10.1002/CNCR.21678

1 reference

26 December 2017

PubMed ID

16456816

1 reference

26 December 2017